[1]
X. Lu, “clinical value of Serum iPTH , ALP and serum markers levels in patients with secondary hyperparathyroidism receiving paricalcitol combined with cinacalcet : clinical value of Serum iPTH and ALP levels”, J Med Biochem, vol. 44, no. 4, pp. 759–769, Mar. 2025, doi: 10.5937/jomb0-55510.